Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis ; volume:26 ; number:1 ; day:1 ; month:3 ; year:2024 ; pages:1-13 ; date:12.2024
Breast cancer research ; 26, Heft 1 (1.3.2024), 1-13, 12.2024
- Creator
-
Smoots, Stephen G.
Schreiber, Anna R.
Jackson, Marilyn M.
Bagby, Stacey M.
Dominguez, Adrian T A.
Dus, Evan D.
Binns, Cameron A.
MacBeth, Morgan
Whitty, Phaedra A.
Diamond, Jennifer R.
Pitts, Todd M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-024-01799-5
- URN
-
urn:nbn:de:101:1-2405052143579.528798476743
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smoots, Stephen G.
- Schreiber, Anna R.
- Jackson, Marilyn M.
- Bagby, Stacey M.
- Dominguez, Adrian T A.
- Dus, Evan D.
- Binns, Cameron A.
- MacBeth, Morgan
- Whitty, Phaedra A.
- Diamond, Jennifer R.
- Pitts, Todd M.
- SpringerLink (Online service)
Other Objects (12)
Yo I El Peshkado "Oki Oki"
Yo I El Peshkado "Oki Oki"
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Overcoming RAD18-mediated temozolomide resistance in glioma cells by class I HDAC inhibition
Itaru Oki : Portrait des Jazzmusikers Itaru Oki
OKiN
OKiR
ZiOKi"
?OKiR?
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Kanagawa oki nami ura
Yo I El Peshkado "Oki Oki"
Yo I El Peshkado "Oki Oki"
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Overcoming RAD18-mediated temozolomide resistance in glioma cells by class I HDAC inhibition
Itaru Oki : Portrait des Jazzmusikers Itaru Oki
OKiN
OKiR
ZiOKi"
?OKiR?
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Kanagawa oki nami ura
Yo I El Peshkado "Oki Oki"
Yo I El Peshkado "Oki Oki"
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Overcoming RAD18-mediated temozolomide resistance in glioma cells by class I HDAC inhibition
Itaru Oki : Portrait des Jazzmusikers Itaru Oki
OKiN
OKiR
ZiOKi"
?OKiR?
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer